Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AKRO - Akero Therapeutics: A Promising Solution For NASH Patients And Investors

AKRO - Akero Therapeutics: A Promising Solution For NASH Patients And Investors

Akero Therapeutics Inc.

2023-05-18 02:17:39 ET

Summary

  • Strong clinical results, including significant reductions in liver fat, improvements in glycemic control, and fibrosis regression without worsening of NASH, support the efficacy and potential of EFX.
  • Akero Therapeutics' ongoing Phase 2b and Phase 3 trials highlight its commitment to advancing its clinical programs and capturing a substantial share of the NASH market.
  • The positive clinical data, along with Akero's competitive advantage in the NASH market, enhance its potential for success in addressing the significant unmet medical need.

For further details see:

Akero Therapeutics: A Promising Solution For NASH Patients And Investors
Stock Information
Company Name: Akero Therapeutics Inc.
Stock Symbol: AKRO
Market: NYSE
Website: akerotx.com
Menu
AKRO AKRO Quote AKRO Short AKRO News AKRO Articles AKRO Message Board
Get AKRO Alerts

News, Short Squeeze, Breakout and More Instantly...